Menopause genetics is a nuanced area. Genome-wide association studies (GWAS) have identified variants in genes like MCM8, BRIP1, and FSHB that are linked to the timing of natural menopause. These can slightly increase the risk of early menopause (before age 45). However, these markers explain only a small fraction of the variation—lifestyle, hormonal status, and environmental factors play a much larger role. A DNA test from MyBody-X or similar companies can detect such variants, but the clinical utility is limited. There are no validated genetic scores that predict menopause trajectory or symptoms like hot flashes, sleep disturbances, or mood changes. Moreover, many direct-to-consumer tests lack regulatory approval. Important: Menopause is a natural life stage, not a disease. Genetic information should always be interpreted alongside medical advice, hormone measurements, and personal symptoms. Without professional guidance, such testing may cause unnecessary worry. Evidence: primarily GWAS-based, not diagnostic.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-39b9a9a2b448a03b0fcd9546